Dr. John Domagala has worked with TSRL as a consultant and scientific advisor since 2010. John was trained as a synthetic medicinal chemist and has 45 years of experience in antiinfective drug design, microbiology and drug development. John spent 30 years and Warner-Lambert/Pfizer working on multiple drug classes and mechanisms. He became the Senior Director of Infectious diseases with responsibility for over 30 projects form screening to IND submission. He served on the In-License Team evaluating over 100 drug opportunities at all stages of development leading to the acquisition of several compounds and two companies. After Pfizer closed its doors in Ann Arbor John became a consultant guiding Universities and Biotech Companies through the process of Antibacterial and Antiviral drug development. With Pfizer and as a consultant John has served on multiple interdisciplinary teams tasked with taking compounds from Lead to IND, learning the importance of fit-for-purpose development studies within budget constraints. John brings this knowledge and experience with leadership capabilities to TSRL.
This person is not in the org chart